期刊
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
卷 5, 期 5, 页码 -出版社
WILEY
DOI: 10.1002/rth2.12546
关键词
antifibrinolytic agents; blood coagulation; contraceptive agents; thrombosis; tranexamic acid
Tranexamic acid (TXA) is a commonly used antifibrinolytic agent for the treatment or prevention of bleeding, with indications ranging from heavy menstrual bleeding to traumatic brain injury. Despite robust evidence, hesitancy in using TXA persists in many clinical settings.
Tranexamic acid (TXA) is an antifibrinolytic agent commonly used for the treatment or prevention of bleeding. Indications for TXA are diverse, including heavy menstrual bleeding, trauma, postpartum hemorrhage, traumatic brain injury, and surgical site bleeding. Despite decades of use and a robust body of evidence, hesitancy using TXA persists in many clinical settings. This illustrated review describes the history, pharmacology, and practical considerations of TXA use. We also describe the major landmark randomized controlled trials of TXA and their implications. Finally, we review the evidence around common controversies surrounding TXA such as the risk of thrombosis, prescription along with combined hormonal contraceptives, and use in patients with gross hematuria.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据